Connection

Paolo Bonfanti to Antibodies, Monoclonal, Humanized

Back to Details
This is a "connection" page, showing publications Paolo Bonfanti has written about Antibodies, Monoclonal, Humanized.
Paolo Bonfanti
Connection Strength
0.106
Antibodies, Monoclonal, Humanized
  1. Therapy of Severe Acute Respiratory Syndrome Coronavirus 2 Pneumonia: Is There an Optimal Interleukin 6 Cutoff for Successful Tocilizumab Treatment? Clin Infect Dis. 2021 07 01; 73(1):e270-e271.
    View in: PubMed
    Score: 0.048
  2. Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial. J Transl Med. 2020 10 21; 18(1):405.
    View in: PubMed
    Score: 0.046
  3. An immune-based biomarker signature is associated with mortality in COVID-19 patients. JCI Insight. 2021 01 11; 6(1).
    View in: PubMed
    Score: 0.012
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.